Refrigeration, cryopreservation and pathogen inactivation: an updated perspective on platelet storage conditions

被引:26
作者
Waters, L. [1 ,2 ]
Cameron, M. [1 ,2 ]
Padula, M. P. [2 ]
Marks, D. C. [1 ]
Johnson, L. [1 ]
机构
[1] Australian Red Cross Blood Serv, Res & Dev, 17 ORiordan St, Alexandria, NSW 2015, Australia
[2] Univ Technol Sydney, Sch Life Sci, Sydney, NSW, Australia
关键词
cold; cryopreservation; pathogen inactivation; platelet; storage; ULTRAVIOLET C LIGHT; REDUCTION TECHNOLOGY MIRASOL; SEPTIC TRANSFUSION REACTIONS; BLOOD-DERIVED PLATELETS; AMOTOSALEN-HCL S-59; IN-VITRO EVALUATION; WEST-NILE-VIRUS; ADDITIVE SOLUTIONS; BACTERIAL-CONTAMINATION; APHERESIS PLATELETS;
D O I
10.1111/vox.12640
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Conventional storage of platelet concentrates limits their shelf life to between 5 and 7 days due to the risk of bacterial proliferation and the development of the platelet storage lesion. Cold storage and cryopreservation of platelets may facilitate extension of the shelf life to weeks and years, and may also provide the benefit of being more haemostatically effective than conventionally stored platelets. Further, treatment of platelet concentrates with pathogen inactivation systems reduces bacterial contamination and provides a safeguard against the risk of emerging and re-emerging pathogens. While each of these alternative storage techniques is gaining traction individually, little work has been done to examine the effect of combining treatments in an effort to further improve product safety and minimize wastage. This review aims to discuss the benefits of alternative storage techniques and how they may be combined to alleviate the problems associated with conventional platelet storage.
引用
收藏
页码:317 / 328
页数:12
相关论文
共 135 条
  • [21] Dickson M, 2013, NEW ZEAL MED J, V126, P12
  • [22] Emerging pathogens and their implications for the blood supply and transfusion transmitted infections
    Dodd, Roger Y.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 (02) : 135 - 142
  • [23] Assessment of the Clinical Performance of Platelet Concentrates Treated by VI Pathogen Reduction Technology in Santiago de Compostela
    Dolores Vilarino, M.
    Castrillo, Azucena
    Campos, Alfredo
    Kilian, Rachel
    Villamayor, Mercedes
    Cardoso, Marcia
    [J]. TRANSFUSION MEDICINE AND HEMOTHERAPY, 2017, 44 (01) : 5 - 9
  • [24] In vitro pH effects on in vivo recovery and survival of platelets: an analysis by the BEST Collaborative
    Dumont, Larry J.
    AuBuchon, James P.
    Gulliksson, Hans
    Slichter, Sherrill J.
    Elfath, M. Dean
    Holme, Stein
    Murphy, James R.
    Rose, Leslie E.
    Popovsky, Mark A.
    Murphy, Scott
    [J]. TRANSFUSION, 2006, 46 (08) : 1300 - 1305
  • [25] A randomized controlled trial evaluating recovery and survival of 6% dimethyl sulfoxide-frozen autologous platelets in healthy volunteers
    Dumont, Larry J.
    Cancelas, Jose A.
    Dumont, Deborah F.
    Siegel, Alan H.
    Szczepiorkowski, Zbigniew M.
    Rugg, Neeta
    Pratt, P. Gayle
    Worsham, D. Nicole
    Hartman, Elizabeth L.
    Dunn, Susan K.
    O'Leary, Margaret
    Ransom, Janet H.
    Michael, Rodney A.
    Macdonald, VictorW.
    [J]. TRANSFUSION, 2013, 53 (01) : 128 - 137
  • [26] Emerging viral threats to the Australian blood supply
    Dunstan, Robert A.
    Seed, Clive R.
    Keller, Anthony J.
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2008, 32 (04) : 354 - 360
  • [27] Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006)
    Eder, Anne F.
    Kennedy, Jean M.
    Dy, Beth A.
    Notari, Edward P.
    Weiss, John W.
    Fang, Chyang T.
    Wagner, Stephen
    Dodd, Roger Y.
    Benjamin, Richard J.
    [J]. TRANSFUSION, 2007, 47 (07) : 1134 - 1142
  • [28] Platelet transfusions in haematology patients: are we using them appropriately?
    Estcourt, L. J.
    Birchall, J.
    Lowe, D.
    Grant-Casey, J.
    Rowley, M.
    Murphy, M. F.
    [J]. VOX SANGUINIS, 2012, 103 (04) : 284 - 293
  • [29] Pathogen-reduced platelets for the prevention of bleeding
    Estcourt, Lise J.
    Malouf, Reem
    Hopewell, Sally
    Trivella, Marialena
    Doree, Carolyn
    Stanworth, Simon J.
    Murphy, Michael F.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (07):
  • [30] Inactivation of dengue, chikungunya, and Ross River viruses in platelet concentrates after treatment with ultraviolet C light
    Faddy, Helen M.
    Fryk, Jesse J.
    Prow, Natalie A.
    Watterson, Daniel
    Young, Paul R.
    Hall, Roy A.
    Tolksdorf, Frank
    Sumian, Chryslain
    Gravemann, Ute
    Seltsam, Axel
    Marks, Denese C.
    [J]. TRANSFUSION, 2016, 56 (06) : 1548 - 1555